FZMD
Price
$0.09
Change
-$0.00 (-0.00%)
Updated
Aug 22 closing price
Capitalization
6.39M
GRRMF
Price
$51.41
Change
-$0.24 (-0.46%)
Updated
Aug 5 closing price
Capitalization
1.86B
Interact to see
Advertisement

FZMD vs GRRMF

Header iconFZMD vs GRRMF Comparison
Open Charts FZMD vs GRRMFBanner chart's image
Fuse Medical
Price$0.09
Change-$0.00 (-0.00%)
Volume$1K
Capitalization6.39M
Gerresheimer AG
Price$51.41
Change-$0.24 (-0.46%)
Volume$100
Capitalization1.86B
FZMD vs GRRMF Comparison Chart in %
Loading...
FZMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GRRMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FZMD vs. GRRMF commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FZMD is a Hold and GRRMF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (FZMD: $0.09 vs. GRRMF: $51.41)
Brand notoriety: FZMD and GRRMF are both not notable
FZMD represents the Medical/Nursing Services, while GRRMF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: FZMD: 33% vs. GRRMF: 36%
Market capitalization -- FZMD: $6.39M vs. GRRMF: $1.86B
FZMD [@Medical/Nursing Services] is valued at $6.39M. GRRMF’s [@Pharmaceuticals: Other] market capitalization is $1.86B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $229.51B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.92B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.67B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FZMD’s FA Score shows that 1 FA rating(s) are green whileGRRMF’s FA Score has 0 green FA rating(s).

  • FZMD’s FA Score: 1 green, 4 red.
  • GRRMF’s FA Score: 0 green, 5 red.
According to our system of comparison, FZMD is a better buy in the long-term than GRRMF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FZMD’s TA Score shows that 5 TA indicator(s) are bullish while GRRMF’s TA Score has 6 bullish TA indicator(s).

  • FZMD’s TA Score: 5 bullish, 2 bearish.
  • GRRMF’s TA Score: 6 bullish, 1 bearish.
According to our system of comparison, both FZMD and GRRMF are a good buy in the short-term.

Price Growth

FZMD (@Medical/Nursing Services) experienced а +26.09% price change this week, while GRRMF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.30%. For the same industry, the average monthly price growth was +2.22%, and the average quarterly price growth was +7.63%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.61%. For the same industry, the average monthly price growth was +2.14%, and the average quarterly price growth was +19.48%.

Industries' Descriptions

@Medical/Nursing Services (+1.30% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+3.61% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GRRMF($1.86B) has a higher market cap than FZMD($6.39M). GRRMF has higher P/E ratio than FZMD: GRRMF (23.97) vs FZMD (1.34). FZMD YTD gains are higher at: 15.395 vs. GRRMF (-26.294). GRRMF has higher annual earnings (EBITDA): 422M vs. FZMD (4.35M). GRRMF has more cash in the bank: 203M vs. FZMD (253K). FZMD has less debt than GRRMF: FZMD (2.22M) vs GRRMF (2.21B). GRRMF has higher revenues than FZMD: GRRMF (2.19B) vs FZMD (18.4M).
FZMDGRRMFFZMD / GRRMF
Capitalization6.39M1.86B0%
EBITDA4.35M422M1%
Gain YTD15.395-26.294-59%
P/E Ratio1.3423.976%
Revenue18.4M2.19B1%
Total Cash253K203M0%
Total Debt2.22M2.21B0%
FUNDAMENTALS RATINGS
FZMD vs GRRMF: Fundamental Ratings
FZMD
GRRMF
OUTLOOK RATING
1..100
923
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
55
Fair valued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
10086
PRICE GROWTH RATING
1..100
4189
P/E GROWTH RATING
1..100
1572
SEASONALITY SCORE
1..100
4550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FZMD's Valuation (45) in the null industry is in the same range as GRRMF (55). This means that FZMD’s stock grew similarly to GRRMF’s over the last 12 months.

FZMD's Profit vs Risk Rating (97) in the null industry is in the same range as GRRMF (100). This means that FZMD’s stock grew similarly to GRRMF’s over the last 12 months.

GRRMF's SMR Rating (86) in the null industry is in the same range as FZMD (100). This means that GRRMF’s stock grew similarly to FZMD’s over the last 12 months.

FZMD's Price Growth Rating (41) in the null industry is somewhat better than the same rating for GRRMF (89). This means that FZMD’s stock grew somewhat faster than GRRMF’s over the last 12 months.

FZMD's P/E Growth Rating (15) in the null industry is somewhat better than the same rating for GRRMF (72). This means that FZMD’s stock grew somewhat faster than GRRMF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FZMDGRRMF
RSI
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
17%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
60%
Bullish Trend 1 day ago
30%
Momentum
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
39%
MACD
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
34%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
31%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
40%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 29 days ago
25%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
50%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
49%
View a ticker or compare two or three
Interact to see
Advertisement
FZMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GRRMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADAP0.06N/A
+7.21%
Adaptimmune Therapeutics plc
RUN16.380.18
+1.11%
Sunrun
ALNT46.59-0.27
-0.58%
Allient
WAB193.31-2.43
-1.24%
Wabtec
POWW1.43-0.05
-3.38%
Outdoor Holding Company

FZMD and

Correlation & Price change

A.I.dvisor tells us that FZMD and GNGBY have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FZMD and GNGBY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FZMD
1D Price
Change %
FZMD100%
N/A
GNGBY - FZMD
16%
Poorly correlated
-1.37%
DSRLF - FZMD
9%
Poorly correlated
N/A
GNNDY - FZMD
7%
Poorly correlated
-3.92%
FSPKF - FZMD
6%
Poorly correlated
N/A
ESLOY - FZMD
6%
Poorly correlated
-2.46%
More

GRRMF and

Correlation & Price change

A.I.dvisor tells us that GRRMF and SAFLF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GRRMF and SAFLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRRMF
1D Price
Change %
GRRMF100%
N/A
SAFLF - GRRMF
21%
Poorly correlated
N/A
GTHP - GRRMF
6%
Poorly correlated
-1.48%
GNGBY - GRRMF
4%
Poorly correlated
-1.37%
ICCM - GRRMF
3%
Poorly correlated
+14.42%
FZMD - GRRMF
1%
Poorly correlated
N/A
More